We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Scancell Holdings Plc | LSE:SCLP | London | Ordinary Share | GB00B63D3314 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.10 | -1.06% | 9.30 | 9.00 | 9.80 | 9.45 | 9.25 | 9.45 | 458,352 | 16:35:17 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -5.86M | -0.0057 | -16.49 | 97.46M |
Date | Subject | Author | Discuss |
---|---|---|---|
18/7/2023 06:43 | Yep...like I said blaming others, not themselves. Crumby blaming the company...TF blaming the fish....inane blaming PI's. Everyone understands 44% inane...everyone. That's NOT the issue. The issue is YOUR understanding of markets. After all, you've only just worked out that humans aren't mice ! | 2tyke | |
18/7/2023 06:03 | 44% disease control rate (DCR) in ovarian cancer patients in ModiFY monotherapy trial CD4 T cells work ........ now we know that technology exists that can improve that ... do you really think that the checkpoint inhibitor Pharma who can't achieve any where near that are not going to be interested in some sort of tie up ... the only choppy waters we are in is Pi unable to recognise Modi has worked I appreciate the mouse model has not transferred like the immunobody mouse, however it is certainly not a failure if the Ci achieved 44% it would be in phase 3 now ......... many are writing this off ... however for those that are buying and there are plenty ... stay tuned Genmab as we have been told are very happy with data coming from there development and if they take it to trial will be a big lift to Glymab | inanaco | |
17/7/2023 21:52 | Yep, they've feasted on promise....over-indu | 2tyke | |
17/7/2023 21:45 | Well, not much changes. Nana and the club are now back in choppy waters. The club ties are burning and the blazers have long failed to fit the portly stature of the ever ageing personas. | aimbigger | |
17/7/2023 21:28 | It's a dirty job guest speaking but somebody has to do it. Because you dudes are gonna ask poor ol' Lindy....'what's happened to the stock price ?' And Lindy gonna say...'I have no idea about the stock price'..because she's a honest lady. And then I'm gonna get up and tell you like it is.. The questions you ask highlight the reason you've called this wrong. They are all company issues. There is nothing wrong with the company. You just happen to think that the company is also a 'traded stock ticker'....and you're completely WRONG ! | 2tyke | |
17/7/2023 21:11 | HOW wonderful that we will have you as a guest speaker 2tyke At THE agm do you have screen shot of your invite ?No doubt will you be brining your enlightening graphs on share price movements. , would interested to hear your take on hxxps://www.wsj.com/ and also look for ward to your data on the following Modi-1 44% of patients achieved stable disease for at least 8 weeks, with some patients experiencing a longer duration of disease stability for 4 months or more. Four patients are still ongoing in this cohort. also your views on Scancell has developing pioneering technology platform for producing monoclonal antibodies that recognise glycans with high specificity and affinity. The platform has generated revenues and the antibodies continue to yield compelling results which have led to a new 6-month evaluation by a leading Biotech company. Additional in-house data has illustrated the potential of our antibodies as chimeric antigen receptor T cell (CART) therapies providing the data for a deal with a cell therapy company. interesting that your so humble when you understand so much scientifically important first . look forward to hearing from you with an intelligent honest response | cleanerworldwehope | |
17/7/2023 20:23 | You should know what happens with company presentations in bear markets Chill. Counter-productive. Best wait for sentiment to turn. | 2tyke | |
17/7/2023 20:15 | I wonder when the Company did any investor presentations? Last one I remember was in Q4 last year. | chillpill | |
17/7/2023 20:12 | Oh but they do read it count dracula .....obsessively so. I'm not on the other bb. I will tell it to their faces at the next AGM. Apparently, I'm guest speaker. They are cancelling all the nudge nudge wink wink and getting real next time ! Enjoy the education count....it's free at the moment. | 2tyke | |
17/7/2023 19:46 | 2tyke, If you've got something to say to someone on the other BB then say it there. Its insane behaviour to think they will read what you post here. Maybe you're just one of those that like talking behind someone's back? Anyway... you've only been on here since last Monday, and obsessively so. All very strange indeed. Do you get a kick out of kicking someone when they're down while displaying your over inflated ego? | countbruga | |
17/7/2023 18:01 | Wow...i've read some rubbish bb's, but the sclp LSE bb surely takes the biscuit ! Crumby is ready to sell the entire shop....for a quid...lol Deluded or what ? Times like this eat away at your brain ! You can say that again. With some more than others. Stocks fall much quicker than they rise. A long time to get back where it was. | 2tyke | |
17/7/2023 17:51 | Phoenix You have a valid point regarding the former director and co founder of SCLP, Richard Goodfellow. He has 2.88 million options at 4.5p expiring at the end of this month. No mention was made of his options being extended when the announcement about Linda’s option being extended was made. I don’t know how many shares Goodfellow has or if he has funds available to exercise his options. If he doesn’t have the funds he would be mad not to sell shares he currently holds in order to take up the options. Even at today’s ridiculously low price he can still turn 100% profit in a day. Perhaps he has sold some in the last few days in order to do so. | 888icb | |
17/7/2023 15:58 | Yes...Marcus...compl He needs to be in a lab. Forget markets !! | 2tyke | |
17/7/2023 15:57 | Lol...ee telling someone they are incompetent for selling. You couldn't make it up ! Lollollollollollol.. | 2tyke | |
17/7/2023 15:56 | Again Marcus and his fairy tails. Keep on chatting the stories from SC website as the share price in a free fall. BS walks and so are you. | golcheja | |
17/7/2023 15:47 | Phoenix ....everyone has a price where they'll rationalise losses and sell. Except perhaps EE..,who prefers to drink in pubs with Kazakh directors lying through their teeth whilst he hangs onto every word. He was warned.....in advance. | 2tyke | |
17/7/2023 15:43 | It’s a short term mess with lots of pain but should resolve itself in due course. Once selling is done….time to buy. | phoenixs | |
17/7/2023 15:42 | Yes...such is the need for PI's to try and explain what doesn't need explaining as an 'event'....they are even prepared to roast the goose that they thought laid the golden eggs !! | 2tyke | |
17/7/2023 15:41 | My guess would be an offload from ex director who had options which are due to expire end of the month. Those with very large holdings would not be selling. Cutting their nose to spite their face comes to mind. The biggest shareholders are in it for the long haul. | phoenixs | |
17/7/2023 15:39 | Or EE...instead of making up stories after the event... It could be a completely normal process within a bear market, that you were warned about ....in advance !! Dear oh dear. They're turning on the boss ! Told you they would. | 2tyke | |
17/7/2023 15:25 | Hi Kim !!! Have you got anything 'interesting' to report dear ? ............. Tosh don't be too hard on the car park man. He was only as deluded as the other bulls ! Thought it was about science and data.. When it's actually about fear and greed ! And the way humans behave. All the time ! | 2tyke | |
17/7/2023 15:20 | another day of carnage ! I don't know about a car park, but I do know that this is yet another car crash for a certain cretin. | tosh123 | |
17/7/2023 15:06 | What is pretty clear is that management has made a mess of things over the last couple of weeks. Major errors have been made - though it isn't yet clear what they are and neither is it clear whether they are important in the long term or not. Watch the main holders..... | markingtime | |
17/7/2023 15:02 | Hope so, MT. Yes trials progressing and they are building knowledge in a valuable area. I recall LD mentioning offloading the whole immunobody dna platform not that long ago, and perhaps that strategy can advance further if good data is achieved. But she needs support - I imagine there is nothing more frustrating than trying and trying but no one is biting :) | wigwammer |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions